![]() |
(picture courtesy alsa.org) |
Starting
in August 2014, the “Ice Bucket Challenge” has taken the internet by storm. The
challenge is simple; once nominated, the challengers have to dump a bucket of
ice water over their heads within 24 hours or donate some amount of money to
the Amyotrophic Lateral Sclerosis Foundation. People have performed this
challenge by themselves, with friends, even on top of mountains with a
helicopter. As friends challenge friends, this #IceBucketChallenge has even
reached celebrities such as Bill
Gates, Chris Pratt, the Old Spice Man, George Bush, Oprah, Justin Timberlake,
and more. All this recent media revolving around the ice bucket challenge has
brought in $100 million in donations for the ALS Foundation, and more
importantly, spread awareness about ALS. But...what exactly is ALS?
What is ALS?
ALS
stands for amyotrophic lateral sclerosis and is often referred to as Lou Gehrig’s
Disease or Charcot’s disease.1,2 It is a progressive
neurodegenerative disease that affects nerve cells in the brain and spinal
cord. Motor neurons connect the brain to the spinal cord, and then the spinal
cord to muscles. As these motor neurons degenerate, they can no longer send
signals to the muscle fibers that normally result in muscle movement. The
progressive nature of ALS eventually leads to the death of the motor neurons.
As these motor neurons die, the brain loses the ability to control muscle
movements. As the disease gets progressively worse, patients will eventually be
totally paralyzed. Most patients with ALS will only live for 2 to 5 years.3
How many people are affected by ALS?
ALS
can strike anyone, with no racial, ethnic, or socioeconomic patterns.1,2
Usually, people between the ages of 40 to 70 are affected. ALS is slightly more
common in men than women. It is estimated that 30,000 Americans may have the
disease, and approximately 5,600 people in the United States are diagnosed
every year. Roughly, it occurs in 1 to 3 per every 100,000 people.1
What types of ALS are there?
There
are 2 types of ALS.1,2 Sporadic ALS (SALS) is the most common form
of ALS (90% to 95% of all cases). Like the name suggests, this type of ALS can
affect anyone, anywhere. Another type of ALS is known as familial ALS (FALS),
which is when ALS occurs more than once in a family lineage. This type accounts
for 5% to 10% of all cases. Through research, scientists have identified some
common genes known to be associated with FALS, though not all. There is a third
type of ALS, but this type appears in specific regions of Guam or Papua New
Guinea.1
What are the common signs and symptoms
associated with ALS?
The
early signs and symptoms of ALS vary depending on which motor neurons are
affected.1,2 However, the initial hallmark sign of ALS is muscle
weakness. This weakness can start in the hands, arms, feet, and/or legs.
Typically, muscle weakness develops on one side and it appears gradually. It
can be as subtle as tripping over carpet edges. Muscle mass can decrease and muscles
spontaneously twitch. Sometimes, patients with a lot of these muscle twitches
or jerks complain of muscle soreness and stiffness more than weakness. The
muscles can cramp as well early on in the disease, usually early in the
morning. Some patients have described it as being similar to a muscle cramp
while stretching in bed.
The
muscles controlling swallowing, breathing, and speech can be affected as the
disease spreads.1,2 Patients can experience trouble speaking and the
exaggeration of expressions of emotion, which leads to involuntary, excessive
laughing or crying, called a pseudobulbar affect (PBA). As the disease
progresses, more and more muscles are involved. Shortness of breath and
difficulty in breathing and swallowing can be experienced by patients.
Eventually, the person may have to get a ventilation machine to help with
breathing. But the 5 senses of sight, touch, hearing, taste, and smell are not
affected. Even in the late stages of ALS, bowel, bladder, and cognitive
functions remain normal.
What are common causes or risk factors
for ALS?
Because
most of the ALS cases are sporadic, there are no definitive common causes or
risk factors.1,2 However, military veterans who were deployed during
the Gulf War are approximately twice as likely to develop ALS. Based on an
analysis of a several studies, smoking is associated with an increased risk of
ALS.4 Formaldehyde exposure is also associated with an increased
risk for ALS. But pesticide or herbicide exposure is not.
There
is a genetic test available for FALS.4 Because this type of ALS is
inherited, there are some inheritance patterns that have been identified. One
such test can detect up to 35% of genetic mutations that can cause FALS.5
Why is early diagnosis important?
ALS
is difficult to diagnose.1,2 ALS has no cure, but there are other
neurologic diseases that may look similar to ALS that can be treated, so it is
important to have the correct diagnosis. If the patient does actually have ALS
and the diagnosis is made early, the family can help the patient with
emotional, mental, and moral support, as well as physical support as time
continues. It is also important to note that because ALS is a rare disease,
patients are encouraged to get a second medical opinion for diagnosis.
ALS
also does not have a specific test for its identification.1,2 To
differentiate ALS from other disorders, healthcare workers call this a
“diagnosis of ruling out”. A comprehensive work up is, however, required for
this ruling out process; blood and urine tests, thyroid and parathyroid hormone
tests, spinal tap, X-rays, magnetic resonance imaging (MRI), myelogram, muscle
and/or nerve biopsy, and neurological examination. But early diagnosis is
important for supportive care. Patients with FALS do have an option of getting
genetic testing as mentioned above. However, treatment would not be different.
What medications are used in the
treatment of ALS?
As
mentioned above, ALS has no cure.1,2,4 However, there is a drug called
riluzole that can slightly increase length of survival, by about 2 to 3 months.
Other medications are available to relieve any symptoms patients may
experience.
Riluzole
(Rilutek) does not reverse the damages already done to the neurons.6,11
It affects both signaling pathways and signaling proteins in the central
nervous system. This medication extends the time before a person needs help
breathing with ventilation support. Some of the common side effects from this
medication includes an increase in blood pressure, increase in heart rate,
abdominal pain, diarrhea, loss of appetite, nausea, vomiting, decreased lung
function, feeling weak, joint pain, dizziness, sleepiness, and vertigo. But not
all of these side effects are felt by everyone, or if at all. There are some rare
but serious side effects including cardiac arrest, low white blood cells or
neutropenia, increased liver function tests, hepatitis, jaundice, or
interstitial lung disease. Remember to always talk to a physician or pharmacist
with any questions about side effects and medications.
As
mentioned before, there are some medications available to help treat some of
the symptoms caused by ALS, such as fatigue, muscle cramps, muscle spasms,
excess saliva, pain, depression, sleep disturbances, and constipation.1-3
The possible treatment options are summarized below.
●
Drooling: Botulinum toxin type B or low-dose radiation therapy
to salivary glands can help decrease or stop drooling.
●
Excessive
laughing or crying: (also known as
pseudobulbar affect or involuntary emotional expression disorder) Nuedexta
(dextromethorphan and quinidine) is recommended.
●
Fatigue: There are no medications currently to help with
fatigue. Riluzole can actually cause fatigue in some people, so talk to your
physician if you are feeling tired while taking riluzole.
●
Spasms: There is no specific recommendation, but
benzodiazepines, baclofen, dantrolene, and tizanidine have been used in
patients with multiple sclerosis and cerebral palsy, who also experience muscle
spasms.
●
Cramps: Similar to spasms, there are no specific
recommendations, but there are treatments that can be tried. Gabapentin,
vitamin E, and riluzole have been used for this indication, however, studies
that did look that these medications show that they may not help everyone.
●
Depression: There are no recommendations on a specific
medication, but there are many effective treatments available.
●
Insomnia: Just like depression, there are no specific
recommendations, but there are also many treatment options.
Earlier
on in the disease state, there are some rehabilitative options to assist ALS
patients.1 Foot-drop splints can help prevent someone from tripping.
Finger extension slips can help someone get a better hand grip on items. Diet
and nutritional support is especially important for patients with ALS as they
develop problems with swallowing and choking. For difficulty swallowing, a
feeding tube may help restore normal nutrition. For those patients whose
disease states have progressed to respiratory failure, mechanical ventilation
can be an option.
What can I do to prevent ALS?
There
is currently no way to prevent ALS. However, research towards ALS certainly
helps. Scientists can continue to research more effective treatments and
genetic testing to help better the lives of those who have been affected by
ALS.
Where can I find more information on
ALS?
●
GeneTests:
Genetic Testing Available and Near You
https://www.genetests.org/search/disorders.php?search=Amyotrophic%2520Lateral%2520Sclerosis&submit=Search&start=0
https://www.genetests.org/search/disorders.php?search=Amyotrophic%2520Lateral%2520Sclerosis&submit=Search&start=0
●
Muscular
Dystrophy Association, ALS Division Fact Sheet http://static.mda.org/publications/PDF/FA-ALS.pdf
●
National Institute
of Neurological Disorders and Stroke http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/ALS.htm
Written
by:
Yijia
Luo, PharmD Candidate, 2015
UIC
College of Pharmacy
References
1.
Brown RH Jr. Amyotrophic lateral sclerosis and other motor
neuron diseases. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J,
Loscalzo J. eds. Harrison's Principles of
Internal Medicine, 18e. New York, NY: McGraw-Hill; 2012.
http://accesspharmacy.mhmedical.com/content.aspx?bookid=331&Sectionid=40727190.
Accessed August 28, 2014.
2.
Standaert DG, Roberson ED. Treatment of central nervous system
degenerative disorders. In: Brunton LL, Chabner BA,
Knollmann BC. eds. Goodman & Gilman's
The Pharmacological Basis of Therapeutics, 12e. New York, NY: McGraw-Hill;
2011.
http://accesspharmacy.mhmedical.com/content.aspx?bookid=374&Sectionid=41266228.
Accessed August 28, 2014.
3.
Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew
D, Johnston W, et al. Practice parameter update: the care of the patient with
amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and
cognitive/behavioral impairment (an evidence-based review): report of the
Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227-1233. doi:10.1212/WNL.0b013e3181bc01a4.
4.
Dynamed [online database]. Ipswich, MA: EBSCOHost; 2014. http://search.ebscohost.com/login.aspx?direct=true&db=dme&AN=116744&site=dynamed-live&scope=site.
Updated June 25, 2014. Accessed September 2, 2014.
5.
ALS DNA Tests Available. Muscular Dystrophy Association
website. http://mda.org/alsn/als-dna-tests-available. Accessed September 17,
2014.
6.
Rilutek [package insert]. Bridgewater, NJ: Sanofi-Aventis;
2012.
No comments:
Post a Comment